2012 Fiscal Year Final Research Report
Intrathecal infusion of thrombolytic agent and/or vasodilator from cisterna magna for prevention and therapy of angiospasm
| Project/Area Number |
22591580
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Cerebral neurosurgery
|
|---|
| Research Institution | Kanazawa University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Keywords | 大槽 / 血栓溶解 / 脳血管攣縮 |
|---|
| Research Abstract |
Intrathecal infusion of tissure plasminogen activator between 24 and 72 hours after subarachnoid hemorrhage can prevent the angiospasm. Clearance of subarachnoid hemorrhage by thrombolytic agent is necessary for the vasodilator agent reaching the vascular wall. I t is also confirmed that vasodilator agent of SNP is most useful for the therapy of the angiospasm.
|
Research Products
(1 results)
